Edit |   |
---|---|
Antigenic Specificity | IL23A, Human (Risankizumab biosimilar) |
Clone | Risankizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IL23A Recombinant Antibody (Risankizumab). Risankizumab, sold under the brand name Skyrizi, is a humanized monoclonal antibody targeting interleukin 23A (IL-23A). Risankizumab is part of a collaboration between Boehringer Ingelheim and AbbVie. |
Immunogen | n/a |
Other Names | Anti-IL23A Recombinant Antibody, Research Grade Risankizumab, Anti-Human IL23A Recombinant Antibody(Risankizumab), BI 655066, risankizumab-rzaa, Antibody Drug Analogues, Monoclonal Antibody, YR1385, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1612838-76-2 |
Catalog # | YR1385 |
Price | please inquire |
Order / More Info | IL23A, Human (Risankizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |